Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.24B 12.92M 11.07M 10.32M 9.47M 17.8M 18.15M 122M 47.75M 620M 48.53M 47.47M 2.05B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.65B 17.22M 14.74M 13.76M 12.62M 23.72M 24.19M 163M 63.62M 826M 64.66M 63.25M 2.73B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day+0.45%
1 week-6.63%
Current month-6.28%
1 month-6.74%
3 months-8.53%
6 months+11.44%
Current year-16.64%
1 week 21.5
Extreme 21.5
24.3
1 month 21.5
Extreme 21.5
25.5
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
49.23
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
+0.45%-6.63%-53.11%-75.95% 12.87M
+2.56%-1.21%+21.60%+101.59% 97.79B
+0.62%-2.33%+51.54%+164.20% 53.13B
0.00%-2.68%+2.47%+279.08% 23.75B
-2.82%-3.52%-14.88%-15.90% 8.28B
-6.08%-4.94%-38.65%-25.33% 7.8B
+0.42%-0.54%-15.53%-21.46% 6.6B
+0.88%-3.48%+4.43%+19.93% 6.29B
-0.12%+1.79%-3.68%+18.44% 5.16B
+1.07%+3.59%+8.68%+20.01% 3.72B
Average -0.45%-1.86%-3.71%+46.46% 21.25B
Weighted average by Cap. +1.01%-1.82%+20.81%+118.15%

Financials

2025 2026
Net sales 2.93B 30.58M 26.18M 24.43M 22.41M 42.11M 42.94M 290M 113M 1.47B 115M 112M 4.85B 2.7B 28.24M 24.18M 22.56M 20.7M 38.89M 39.66M 268M 104M 1.35B 106M 104M 4.48B
Net income 251M 2.62M 2.24M 2.09M 1.92M 3.61M 3.68M 24.83M 9.68M 126M 9.84M 9.62M 416M 14.17M 148K 127K 118K 109K 204K 208K 1.4M 547K 7.1M 556K 544K 23.51M
Net Debt 127M 1.33M 1.14M 1.06M 975K 1.83M 1.87M 12.6M 4.91M 63.76M 4.99M 4.88M 211M 411M 4.3M 3.68M 3.43M 3.15M 5.92M 6.03M 40.71M 15.87M 206M 16.13M 15.78M 682M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
26-08-21 22.40 +0.45% 50,714
26-08-20 ₹22.30 -6.26% 139,295
26-08-19 ₹23.79 +0.30% 30,405
26-08-18 ₹23.72 -2.02% 27,297
26-08-17 ₹24.21 +0.88% 27,550
  1. Stock Market
  2. Stocks
  3. BALAXI Stock